These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30150212)

  • 21. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.
    Milman G; Barnes AJ; Schwope DM; Schwilke EW; Darwin WD; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Clin Chem; 2010 Aug; 56(8):1261-9. PubMed ID: 20530732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy-∆9-THC in Hair.
    Hill VA; Schaffer MI; Paulsen RB; Stowe GN
    J Anal Toxicol; 2022 May; 46(5):487-493. PubMed ID: 34153110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
    Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
    Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of prenatal marijuana use: evaluation of the correlation between self-report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals.
    Metz TD; McMillin GA; Silver RM; Allshouse AA; Heard K; Jensen TL; Wymore EM; Stickrath E; Conageski C; Kinney GL; Binswanger IA
    Addiction; 2022 Jan; 117(1):172-181. PubMed ID: 34142398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD; Worth D
    Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of Cannabinoids in Breath Samples Using a Novel Derivatization LC-MS/MS Assay with Ultra-High Sensitivity.
    Luo YR; Yun C; Lynch KL
    J Anal Toxicol; 2019 Jun; 43(5):331-339. PubMed ID: 30951168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
    Uhl M; Sachs H
    Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid Stability in Antemortem and Postmortem Blood.
    Meneses V; Mata D
    J Anal Toxicol; 2020 Mar; 44(2):126-132. PubMed ID: 31711171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
    Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
    J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of cannabinoids in human cerumen samples by use of UPLC-MS/MS as a potential biomarker for drug use.
    Christodoulou MC; Constantinou MS; Louppis AP; Christou A; Stavrou IJ; Kapnissi-Christodoulou CP
    J Pharm Biomed Anal; 2023 Jul; 231():115412. PubMed ID: 37087774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid disposition in oral fluid after controlled smoked cannabis.
    Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
    Clin Chem; 2012 Apr; 58(4):748-56. PubMed ID: 22273566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.
    Kieliba T; Lerch O; Andresen-Streichert H; Rothschild MA; Beike J
    Drug Test Anal; 2019 Feb; 11(2):267-278. PubMed ID: 30144294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
    Milman G; Schwope DM; Gorelick DA; Huestis MA
    Clin Chim Acta; 2012 Apr; 413(7-8):765-70. PubMed ID: 22285315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Cannabinoids by LC-MS-MS and ELISA in Breast Milk.
    Sempio C; Wymore E; Palmer C; Bunik M; Henthorn TK; Christians U; Klawitter J
    J Anal Toxicol; 2021 Aug; 45(7):686-692. PubMed ID: 33002141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potency testing of up to twenty cannabinoids by liquid chromatography diode array detector with optional electrospray ionization time-of-flight mass spectrometry.
    Song L; Valenzuela G; Carlson S; Dodson Z; Adisa M
    Anal Chim Acta; 2022 May; 1207():339827. PubMed ID: 35491034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.